Pharmaceutical Chemistry — 04
Sample dilution procedure
Bringing a 20 % w/v solution down to the BP working concentration, and bracketing it with a calibration series prepared from certified reference material.
Label strength
200 mg/ml
Working conc.
2000 μg/ml
Dilution
1.00 → 100 ml
Calibration range
80 – 120 %
4.1
Overview and rationale
The dilution procedure for this assay serves two purposes:
- 01Reducing the nebulizing solution from its labelled 20 % w/v strength down to a concentration suitable for HPLC injection.
- 02Preparing a series of calibration standards from Acetylcysteine Certified Reference Material (CRM) that bracket the sample concentration, allowing accurate quantification against a calibration curve.
Both the sample and standards are diluted using the same diluent to prevent solvent-mismatch effects on peak shape and retention time.
4.2
Diluent selection
The mobile phase (10 volumes methanol : 90 volumes 0.5 % ammonium sulphate solution containing 0.02 M sodium pentanesulphonate, adjusted to pH 2.0 with 2 M hydrochloric acid) was selected as the diluent for both sample and standards, consistent with the method prescribed in the BP monograph for Acetylcysteine Injection (British Pharmacopeia Commission, 2022). This was chosen for three reasons:
Chromatographic compatibility
Diluting with the mobile phase eliminates any solvent disturbance or peak distortion that can occur when a sample is injected in a diluent stronger or more mismatched than the mobile phase.
pH stabilisation
The low pH (2.0) of the mobile phase supressed base-catalysed oxidation of acetylcysteine's free thiol (-SH) group, which is accelerated at neutral or alkaline pH. This directly protects the analyte between dilution and injection.
Consistency with BP standards
Per Appendix III D, any pH adjustment must be made to the aqueous component of the mobile phase rather than the final mixture.
4.3
Handling and timing precautions
Because acetylcysteine is oxygen-sensitive, the following precautions must be taken during the dilution process to prevent chemical degradation:
- —All dilutions are prepared for immediate use rather than in advance, minimizing the window for oxidative degradation between preparation and injection.
- —Volumetric flasks are filled with minimal headspace and capped promptly after mixing to limit air exposure.
- —Standards and samples are protected from direct light during preparation and amber glassware for storage should be used.
4.4
Equipment and precision considerations
Class A volumetric glassware is specified throughout, rather than Class B or graduated equipment, because the tolerances of the equipment affect the reliability of the final calculated concentration:
| Glassware | Tolerance |
|---|---|
| 1 ml bulb pipette | ±0.007 ml |
| 5 ml bulb pipette | ±0.015 ml |
| 10 ml volumetric flask | ±0.02 ml |
| 100 ml volumetric flask | ±0.08 ml |
Using Class A volumetric glassware keeps the compounded error across a series dilution well under 1 %, which matters here because the assay's acceptance criteria (accuracy 95–105 %, precision RSD ≤ 2 %, per BP) leave little room for dilution error.
4.5
Primary sample dilution
At 20 % w/v, the nebulizing solution contains 200 mg/ml of acetylcysteine. The target working concentration, consistent with the BP monograph for Acetylcysteine Injection, is 0.2 % w/v (2000 μg/ml) (British Pharmacopeia Commission, 2022).
Using C₁V₁ = C₂V₂
Procedure
- 01Accurately pipette 1.00 ml of the 20 % w/v nebulizing solution into a 100 ml Class A volumetric flask using a Class A bulb pipette.
- 02Dilute to volume with mobile phase and invert at least 10 times to ensure homogeneity (do not shake vigorously, to avoid introducing oxygen or air into the solution).
- 03Resulting concentration: (200 mg/ml × 1.00 ml) ÷ 100 ml = 2 mg/ml (0.2 % w/v, 2000 μg/ml).
This matches the BP-prescribed working concentration of Acetylcysteine Injection, placing the sample at the same concentration as the calibration midpoint (Section 4.7), which minimizes extrapolation error when reading the result off the calibration curve.
4.6
CRM stock solution
Procedure
- 01Accurately weigh 40.0 mg of acetylcysteine CRM.
- 02Transfer to a 10.0 ml volumetric flask and dissolve in a small amount of mobile phase.
- 03Dilute to volume with mobile phase to give a 4.0 mg/ml (0.4 % w/v, 4000 μg/ml) stock solution.
- 04Prepare fresh. Do not store beyond the working session, given the oxidation risk discussed in Section 4.3.
4.7
Calibration standard series
A bracketing calibration series (80–120 % of the target working concentration) was constructed from the CRM stock solution, using the dilution equation C₁V₁ = C₂V₂, where C₁ and V₁ are the concentration and volume of the stock solution, and C₂ and V₂ are the concentration and volume of the final standard:
| % of target | Target conc. (μg/ml) | Stock required (ml) | Diluted to (ml) |
|---|---|---|---|
| 80 % | 1600 | 4.00 | 10.00 |
| 90 % | 1800 | 4.50 | 10.00 |
| 100 % | 2000 | 5.00 | 10.00 |
| 110 % | 2200 | 5.50 | 10.00 |
| 120 % | 2400 | 6.00 | 10.00 |
Each standard is mixed by inversion and transferred to an amber HPLC vial immediately prior to injection.
Worked example — 100 % standard
4.8
Why an 80–120 % bracketing range was chosen
This calibration range was chosen deliberately, based on the following considerations:
- 01The sample is expected to measure at approximately 100 % of its labelled concentration; a range of 80–120 % places this expected value at the centre of the calibration curve rather than near either extreme. Measurements towards the edge of a calibration curve or range are inherently less reliable, so centring the expected result within the curve supports a more accurate and reliable determination.
- 02The range reflects standard practice for an assay of this type. Because the purpose here is to confirm drug content against the label claim, rather than to detect trace impurities, the expected result will always lie close to 100 % of the stated strength. A narrow, targeted calibration range is therefore more appropriate than a broad range designed to capture widely varying concentrations, as would be used in an impurity-focused method.